Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Viatris Inc (VTRS)

Viatris Inc (VTRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,174,911
  • Shares Outstanding, K 1,207,083
  • Annual Sales, $ 11,946 M
  • Annual Income, $ -669,900 K
  • 60-Month Beta 1.55
  • Price/Sales 1.34
  • Price/Cash Flow 10.15
  • Price/Book 0.68
Trade VTRS with:
  • Price/Earnings ttm 2.81
  • Earnings Per Share ttm 3.33
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/10/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 43.11%
  • Historical Volatility 24.82%
  • IV Percentile 36%
  • IV Rank 5.45%
  • IV High 335.48% on 11/19/20
  • IV Low 26.24% on 03/23/21
  • Put/Call Vol Ratio 0.62
  • Today's Volume 4,245
  • Volume Avg (30-Day) 9,402
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 289,660
  • Open Int (30-Day) 270,697

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.80
  • Number of Estimates 4
  • High Estimate 0.85
  • Low Estimate 0.77
  • Prior Year 0.90
  • Growth Rate Est. (year over year) -11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.94 +3.32%
on 04/13/21
14.94 -10.48%
on 03/22/21
-1.41 (-9.54%)
since 03/19/21
3-Month
12.94 +3.32%
on 04/13/21
18.68 -28.43%
on 02/18/21
-4.07 (-23.34%)
since 01/19/21

Most Recent Stories

More News
Viatris Inc. to Release First Quarter 2021 Financial Results on May 10, 2021

, /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2021 financial results on , before the open of the U.S. financial markets. The company also will host a webcast at on...

VTRS : 13.35 (-0.37%)
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol

and , /PRNewswire/ --  (NASDAQ: VTRS) and  today announced that the U.S. Food and Drug Administration (FDA) granted tentative approval of budesonide/formoterol fumarate dihydrate products, the first...

VTRS : 13.35 (-0.37%)
Viatris Inc. to Participate in Barclays Global Healthcare Conference

, /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Barclays Global Healthcare Conference on . CEO , President and Chief Financial...

VTRS : 13.35 (-0.37%)
Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platform, and Focus on CSR and Financial Commitments

, /PRNewswire/ -- At a virtual meeting with the investment community today, Viatris Inc. (NASDAQ: VTRS) will outline how the company expects to lead as a new kind of healthcare company with a unique...

VTRS : 13.35 (-0.37%)
Theravance (TBPH) Q4 Earnings Top Estimates, Revenues In Line

Theravance's (TBPH) loss narrows in the fourth quarter of 2020 while revenues meet the consensus estimate.

JNJ : 162.70 (+0.28%)
GSK : 37.98 (+0.61%)
TBPH : 21.19 (-2.40%)
VTRS : 13.35 (-0.37%)
Viatris (VTRS) Declines on Lackluster Outlook, Announces Dividend

Viatris (VTRS) declines after it announces outlook for 2021 and reaffirms strategic commitments.

DVAX : 11.46 (+4.28%)
PFE : 38.81 (+0.62%)
RGEN : 209.37 (-1.84%)
VTRS : 13.35 (-0.37%)
Thinking about buying stock in Viatris, Energous Corp, Marathon Oil, Norwegian Cruise Line, or Snap?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTRS, WATT, MRO, NCLH, and SNAP.

VTRS : 13.35 (-0.37%)
WATT : 3.11 (-5.18%)
MRO : 10.57 (+0.38%)
NCLH : 28.26 (-0.21%)
SNAP : 59.20 (-3.35%)
Viatris Inc. Announces 2021 Financial Guidance and Reaffirms Strategic and Financial Commitments

, /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced its 2021 financial guidance and reaffirmed its commitment to rapid de-leveraging, to  enhancing and growing free cash flows, particularly...

VTRS : 13.35 (-0.37%)
Viatris Launches Hulio® (adalimumab biosimilar) in Canada

Viatris Launches Hulio® (adalimumab biosimilar) in Canada

VTRS : 13.35 (-0.37%)
Viatris Inc. to Hold Conference Call on Monday, Feb. 22, 2021, to Discuss 2021 Financial Guidance

, /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that it will host a conference call at 8 a.m. ET on Monday, Feb. 22 to discuss 2021 financial guidance.

VTRS : 13.35 (-0.37%)

Business Summary

Viatris Inc. is a healthcare company. It provides access to medicines, advance sustainable operations, develop solutions and leverage to connect more people to more products and services through Global Healthcare Gateway(TM). Viatris Inc., formerly known as Mylan NV, is based in PITTSBURGH.

See More

Key Turning Points

3rd Resistance Point 13.88
2nd Resistance Point 13.67
1st Resistance Point 13.54
Last Price 13.35
1st Support Level 13.20
2nd Support Level 12.99
3rd Support Level 12.86

See More

52-Week High 18.86
Fibonacci 61.8% 16.60
Fibonacci 50% 15.90
Fibonacci 38.2% 15.20
Last Price 13.35
52-Week Low 12.94

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar